Navigation Links
Arpida Presents Preclinical Data on AR-2474 at ICAAC
Date:9/21/2007

REINACH and BASEL, Switzerland, September 21 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) presented several preclinical studies on its novel topical antibiotic AR-2474 at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases.

AR-2474 is a novel synthetic antibacterial currently under development for topical indications including treatment of infections and prevention of transmission of the "superbug" MRSA. AR-2474 is a diphenyl urea with unique properties.

F1-2100: The topical activity and potency of AR-2474 was compared with the gold standard mupirocin (Bactroban(R)) in two preclinical models of MRSA infection of the skin and of nasal decolonisation. In both models, a preliminary topical formulation of AR-2474 was demonstrated to be as efficacious as mupirocin.

F1-2094, F1-2095, F1-2096, F1-2097, F1-2100A: The in vitro microbiological activity of AR-2474 and of other compounds of the class was assessed in-house and by leading laboratories against large panels of clinical isolates. AR-2474 showed potent activity against methicillin susceptible and resistant staphylococci including nosocomial and community S. aureus isolates. Importantly, AR-2474 exhibits no cross-resistance with other classes of currently used topical treatments. The compound also exhibited potent activity against Group A and B streptococci, enterococci, pneumococci and other important pathogens responsible for causing infections of the skin, eye and mouth.

F1-2099: AR-2474 demonstrated little or no propensity for resistance development. No resistant mutants to AR-2474 could be selected using different methodologies.

F1-2098: The data showed that AR-2474 is bactericidal, exhibits a post antibiotic effect and shows no antagonism wi
'/>"/>

SOURCE Arpida Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  Synthetic Biologics, ... serious infections and diseases, with a focus on protecting the ... Officer, is scheduled to present at the 27th Annual ROTH ... Laguna Niguel in Dana ... on Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). ...
(Date:3/3/2015)...  PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: ... of three shareholder lawsuits filed in the fall of ... February 2, 2015, a securities lawsuit that was filed ... putative class of purchasers of the Company,s stock, Hampe ... Nev.), was voluntarily dismissed without prejudice.  Shortly thereafter, and ...
(Date:3/3/2015)... 2015  Phillip Sharp, Institute Professor at the Massachusetts Institute ... Biology and the Koch Institute for Integrative Cancer Research, will ... Day , May 14, at the Chemical Heritage Foundation. ... Medal since it was first awarded to Ralph ... Phil Sharp gave the scientific world a new view ...
(Date:3/2/2015)... COLUMBIA, Md. (PRWEB) March 02, 2015 ... poster sessions and present on LCMS and marijuana analysis ... takes place March 8 to 12 at the Ernest ... , Attendees can stop by booth 3121 to discuss ... how the company’s innovative, proven products help save time, ...
Breaking Biology Technology:Synthetic Biologics to Present at the 27th Annual ROTH Conference 2PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2Phillip Sharp to Receive 2015 Othmer Gold Medal 2Phillip Sharp to Receive 2015 Othmer Gold Medal 3Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 3
... in Quality by Design Initiative for Protein Therapeutics - ... Sciences, Inc. (Nasdaq: CALP ), a leading ... life sciences research, today launched the Staccato Protein Workstation ... therapeutics and biogenerics. , , With a ...
... Md., June 29 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... 3000 Index as part of the annual reconstitution of ... , , "Investors recognize the Russell 3000 as ...
... ever involving patients with cutaneous T-cell lymphoma on schedule ... RADNOR, Pa., June 29 Yaupon Therapeutics, a privately ... enrollment for a pivotal Phase 2 clinical trial for ... (CTCL - stages 1-2a). The study, which is ...
Cached Biology Technology:Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 2Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 3Micromet Added to Russell 3000 Index 2Micromet Added to Russell 3000 Index 3Micromet Added to Russell 3000 Index 4Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma 2
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... The Institute for Translational Medicine and Therapeutics, 7th ... Personalization and the Science of Scale, to be ... direct relevance to translational science. ITMAT is part ... University of Pennsylvania. , Speakers will include those ...
... a humane option for the control of feral and ... issued by the International Society of Feline Medicine (ISFM) ... published by SAGE. According to the society, which ... Care, culling to control cat populations is also rarely ...
... screening shellfish for fungal toxins is important, say scientists. ... Society for Applied Microbiology (SfAM) journal, Letters in ... contamination by strains of Penicillium fungus, bivalve ... at much higher levels that are found in the ...
Cached Biology News:Lab-on-a-chip tech, brain mapping & microbiome highlighted at translational med meeting 2ISFM takes a stand on welfare of unowned cats 2